Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.
Pharmacoeconomics. 2011 Sep;29(9):807-21. doi: 10.2165/11207220-000000000-00000.
Pharmacoeconomics. 2011.
PMID: 21838333
Review.